Company Profile

Intercell USA, Inc. provides products for the delivery of vaccines to the skin through a proprietary technology known as transcutaneous immunization, or TCI. The Company is evaluating skin immunization techniques in several human clinical trials, including those to prevent influenza in the healthy adult and elderly populations, and also to prevent travelers' diarrhea and anthrax infection.

Employees

Sector

Pharmaceuticals

More about the company

Manager	Title	Age	Since
Franck Grimaud PRN	Corporate Officer/Principal	59	01/12/2015
Reinhard Kandera DFI	Director of Finance/CFO	56	-
Robert C. Seid PRN	Corporate Officer/Principal	-	01/08/2008

Director	Title	Age	Since
Thomas Martin Vernon BRD	Director/Board Member	87	05/07/2006
F. Weller Meyer BRD	Director/Board Member	83	01/01/2006
Richard Douglas BRD	Director/Board Member	73	01/01/2002

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
REGENERON PHARMACEUTICALS, INC.	+1.63%	-2.74%	+17.91%	-18.09%	62.21B
UCB	+0.66%	+4.56%	+66.86%	+221.13%	59.45B
SAMSUNG BIOLOGICS CO.,LTD.	-0.92%	+28.60%	+28.60%	+28.60%	38.9B
CSL LIMITED	+0.26%	+9.80%	-55.40%	-65.15%	36.4B
BIOGEN INC.	+2.94%	+1.79%	+50.28%	-35.26%	29.52B
INCYTE CORPORATION	+2.32%	+6.51%	+56.62%	+76.65%	21.54B
MODERNA, INC.	+7.94%	-3.78%	+78.88%	-59.73%	19.7B
INNOVENT BIOLOGICS, INC.	+4.80%	-0.20%	-5.33%	+112.95%	16.18B
SWEDISH ORPHAN BIOVITRUM AB	-1.23%	-3.67%	+46.73%	+97.34%	15.89B
Average	+2.04%	+1.46%	+31.68%	+39.83%	33.31B
Weighted average by Cap.	+1.55%	+1.87%	+30.35%	+45.26%

Iomai Corporation Stock

Stocks

US46202P1030

Pharmaceuticals

Managers and Directors: Iomai Corporation

Biopharmaceuticals

Company Profile

End-of-day quote Nasdaq Other stock markets
-	-